SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-073749
Filing Date
2024-06-14
Accepted
2024-06-14 16:39:09
Documents
11
Period of Report
2024-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K olma-20240613.htm   iXBRL 8-K 58291
  Complete submission text file 0000950170-24-073749.txt   168523

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT olma-20240613.xsd EX-101.SCH 23852
14 EXTRACTED XBRL INSTANCE DOCUMENT olma-20240613_htm.xml XML 4532
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 241045458
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)